Enzytec

Márcio

Enzytec Confirmed Once Again for Hospitalar 2023

Leave a Comment / Post Destaque - EN /

Enzytec continues to build its history alongside Hospitalar! Over the past 30 years, “Hospitalar” has played a crucial role in developing opportunities in the healthcare sector, connecting the market and disseminating knowledge and debates that drive us forward. And since 2005, throughout Enzytec’s journey, Hospitalar has allowed us to accumulate numerous experiences and valuable partnerships […]

Enzytec Confirmed Once Again for Hospitalar 2023 Read More »

5 Curiosities About the Annual Hospitalar Fair in Brazil

Leave a Comment / Post Destaque - EN /

The Hospitalar Fair is the largest and most important business and networking event in the healthcare sector in Latin America. In addition to bringing together healthcare professionals and companies, the fair promotes the exhibition of products, services, and innovations while offering lectures, workshops, and seminars to foster knowledge and experience exchange. Here are 5 curiosities

5 Curiosities About the Annual Hospitalar Fair in Brazil Read More »

Enzytec Opens Representation In China

Leave a Comment / Post Destaque - EN /

ENZYTEC, a leader in hosting and ANVISA registration services, takes a significant step in expanding its international connections by establishing representation in China. Recently, the company entered into an agreement with two renowned representatives in the country, Chen Tian (Chris) and Dan Zhai (Rosa), who will act as a link between ENZYTEC and the growing

Enzytec Opens Representation In China Read More »

Enzytec launches solution that eliminates the use of Level 2 biosecurity chambers in rapid tests for COVID

Leave a Comment / Sem categoria /

ENZYTEC NEWS Enzytec launches solution that eliminates the use of Level 2 biosecurity chambers in rapid tests for COVID For the development and evaluation of tests for COVID-19, one of the major barriers that manufacturers of IVD kits encounter, due to current legislation, is the need to use Biosafety Level 2 chambers and procedures in

Enzytec launches solution that eliminates the use of Level 2 biosecurity chambers in rapid tests for COVID Read More »

Enzytec supports Medmax in Standardizing the Manufacturing of Rapid Immunochromatographic Tests

Leave a Comment / Sem categoria /

ENZYTEC NEWS Enzytec supports Medmax in Standardizing the Manufacturing of Rapid Immunochromatographic Tests Continuing the partnership with MEDMAX, Enzytec carried out in June 2022 the production of immunochromatographic rapid tests at the company. For the production of the tests, the specifications of humidity (

Enzytec supports Medmax in Standardizing the Manufacturing of Rapid Immunochromatographic Tests Read More »

Hospitalar 2022

Leave a Comment / Sem categoria /

ENZYTEC NEWS Hospitalar 2022 From May 17 to 20, 2022, the 27th edition of Hospitalar took place at São Paulo Expo. In this edition, which was marked by the post-pandemic resumption, we have the support of Anbiotec (National Association of Biotechnology and Life Sciences). During the four days of the fair, we were present at

Hospitalar 2022 Read More »

RDC 687/22

Leave a Comment / Sem categoria /

ENZYTEC NEWS RDC 687/22 The new RDC 687 came into force in May 2022, which provides for the criteria for granting or renewing the Certification of Good Manufacturing Practices for Medical Devices, complementing the general provisions of administrative procedures for granting the Certification of Good Manufacturing Practices. According to the Federal Official Gazette, RDC 687/22,

RDC 687/22 Read More »

Enzytec obtains Sanitary Permit for Importation and Distribution of Health Products according to RDC 16/2013 ANVISA

Leave a Comment / Sem categoria /

ENZYTEC NEWS Enzytec obtains Sanitary Permit for Importation and Distribution of Health Products according to RDC 16/2013 ANVISA In April 2022, Enzytec Biotecnologia obtained the Sanitary Permit for Importation and Distribution of Health Products. With long experience in regulatory consulting and technology development, in this new phase the company will also act as a distributor

Enzytec obtains Sanitary Permit for Importation and Distribution of Health Products according to RDC 16/2013 ANVISA Read More »

RDC 675/22

Leave a Comment / Sem categoria /

ENZYTEC NEWS RDC 675/22 The new RDC 675 came into force in March 2022, which deals with the adequacy of drugs registered until June 2, 2003 and which did not present evidence of therapeutic equivalence at the time of registration. According to ANVISA, RDC 675/22, which revokes RDCs 134/2003, 210/2004, 37/2011 and 98/2016, comes with

RDC 675/22 Read More »